COYA THERAPEUTICS, INC. COMMON STOCK

NASDAQ: COYA (Coya Therapeutics, Inc.)

Kemas kini terakhir: semalam, 5:51PM

5.96

0.18 (3.11%)

  • 1H 3.11%
  • 5H 1.02%
  • 1B 1.36%
  • 6B -3.09%
  • Tahun Ke Tarikh 4.38%
  • 1T -12.22%
  • 5T 30.42%
Penutupan Terdahulu 5.78
Buka 5.85
Jumlah Dagangan 72,677
Purata Dagangan (3B) 59,704
Modal Pasaran 99,681,000
Harga / Jualan (P/S) 25.56
Harga / Buku (P/B) 2.99
Julat 52 Minggu
4.65 (-21%) — 10.24 (71%)
Margin Operasi (TTM) -2,976.89%
EPS Cair (TTM) -1.07
Pertumbuhan Hasil Suku Tahunan (YOY) 103.30%
Nisbah Semasa (MRQ) 8.84
Aliran Tunai Operasi (OCF TTM) -15.26 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -10.29 M
Pulangan Atas Aset (ROA TTM) -32.06%
Pulangan Atas Ekuiti (ROE TTM) -52.11%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Biotechnology (US) Menurun Menurun
Biotechnology (Global) Menurun Menurun
Stok Coya Therapeutics, Inc. Menurun Menurun

AISkor Stockmoo

2.0
Konsensus Penganalisis 4.0
Aktiviti Orang Dalam NA
Volatiliti Harga 2.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal 2.0
Purata 2.00

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
COYA 100 M - - 2.99
VRNA 8 B - - 34.39
RVMD 7 B - - 3.39
IMVT 3 B - - 4.10
CRNX 3 B - - 2.23
IRON 2 B - - 2.68

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Sektor Healthcare
Industri Biotechnology
Gaya Pelaburan Small Core
% Dimiliki oleh Orang Dalam 7.02%
% Dimiliki oleh Institusi 28.07%

Pemilikan

Nama Tarikh Syer Dipegang
Ghp Investment Advisors, Inc. 31 Mar 2025 26,171
20.5520.5517.4017.4014.2514.2511.1011.107.957.95Harga Sasaran MedianQ1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25
Julat 52 Minggu
4.65 (-21%) — 10.24 (71%)
Julat Harga Sasaran
14.00 (134%) — 18.00 (202%)
Tinggi 18.00 (D. Boral Capital, 202.01%) Beli
18.00 (HC Wainwright & Co., 202.01%) Beli
Median 18.00 (202.01%)
Rendah 14.00 (Chardan Capital, 134.90%) Beli
Purata 16.67 (179.70%)
Jumlah 3 Beli
Harga Purata @ Panggilan 6.04
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Chardan Capital 01 Jul 2025 14.00 (134.90%) Beli 5.70
13 May 2025 14.00 (134.90%) Beli 5.76
HC Wainwright & Co. 09 Jun 2025 18.00 (202.01%) Beli 5.88
D. Boral Capital 24 Apr 2025 18.00 (202.01%) Beli 6.53
22 Apr 2025 18.00 (202.01%) Beli 6.64
  • 3M
Tarikh Jenis Butiran
23 Jun 2025 Pengumuman Updated Lineup Announced for iAccess Alpha's Virtual Summer Investment Conference, June 24–25, 2025
18 Jun 2025 Pengumuman iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
18 Jun 2025 Pengumuman Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
02 Jun 2025 Pengumuman Coya Therapeutics Announces Issuance of New U.S. Patent Protecting Methods of Producing Recombinant Human (rh) Interleukin-2 (aldesleukin) Liquid Formulations
16 May 2025 Pengumuman Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
13 May 2025 Pengumuman Coya Therapeutics Reports First Quarter Financial Results and Provides a Corporate Update
08 May 2025 Pengumuman Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025
24 Apr 2025 Pengumuman Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
21 Apr 2025 Pengumuman Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)
17 Apr 2025 Pengumuman Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
6.426.426.116.115.805.805.495.495.185.18Jun 24Jun 24Jun 25Jun 25Jun 26Jun 26Jun 27Jun 27Jun 30Jun 30Jul 1Jul 1Jul 2Jul 2Jul 3Jul 3

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.0500.050-0.000-0.000-0.050-0.050-0.100-0.100-0.150-0.150MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda